These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 23235274)

  • 1. The G protein-coupled receptor GPR30 mediates the nontranscriptional effect of estrogen on the activation of PI3K/Akt pathway in endometrial cancer cells.
    Ge X; Guo R; Qiao Y; Zhang Y; Lei J; Wang X; Li L; Hu D
    Int J Gynecol Cancer; 2013 Jan; 23(1):52-9. PubMed ID: 23235274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear estrogen receptor-mediated Notch signaling and GPR30-mediated PI3K/AKT signaling in the regulation of endometrial cancer cell proliferation.
    Wei Y; Zhang Z; Liao H; Wu L; Wu X; Zhou D; Xi X; Zhu Y; Feng Y
    Oncol Rep; 2012 Feb; 27(2):504-10. PubMed ID: 22075757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogenic transmembrane receptor of GPR30 mediates invasion and carcinogenesis by endometrial cancer cell line RL95-2.
    He YY; Du GQ; Cai B; Yan Q; Zhou L; Chen XY; Lu W; Yang YX; Wan XP
    J Cancer Res Clin Oncol; 2012 May; 138(5):775-83. PubMed ID: 22270964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Influence of pertussis toxin on GPER-mediated activation of phosphatidylinositol 3-kinase/protein kinase B signaling induced by 17β-estradiol in endometrial carcinoma cells].
    Guo RX; Lei J; Wang XY; Ge X; Hu DM; Ma XY; Li LX; Qiao YH
    Zhonghua Fu Chan Ke Za Zhi; 2013 Feb; 48(2):129-33. PubMed ID: 23544495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of estrogen on the proliferation of endometrial cancer cells is mediated by ERRγ through AKT and ERK1/2.
    Sun Y; Wang C; Yang H; Ma X
    Eur J Cancer Prev; 2014 Sep; 23(5):418-24. PubMed ID: 25068805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gankyrin plays an essential role in estrogen-driven and GPR30-mediated endometrial carcinoma cell proliferation via the PTEN/PI3K/AKT signaling pathway.
    Zhang J; Yang Y; Zhang Z; He Y; Liu Z; Yu Y; Wu S; Cai B; Feng Y
    Cancer Lett; 2013 Oct; 339(2):279-87. PubMed ID: 23142288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The G protein-coupled receptor GPR30 mediates the proliferative effects induced by 17beta-estradiol and hydroxytamoxifen in endometrial cancer cells.
    Vivacqua A; Bonofiglio D; Recchia AG; Musti AM; Picard D; Andò S; Maggiolini M
    Mol Endocrinol; 2006 Mar; 20(3):631-46. PubMed ID: 16239258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LSD1 sustains estrogen-driven endometrial carcinoma cell proliferation through the PI3K/AKT pathway via di-demethylating H3K9 of cyclin D1.
    Chen C; Wang Y; Wang S; Liu Y; Zhang J; Xu Y; Zhang Z; Bao W; Wu S
    Int J Oncol; 2017 Mar; 50(3):942-952. PubMed ID: 28098854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of GPER on the activation of PI3K/Akt induced by 17β-estradiol in endometrial carcinoma cells].
    Zhang YC; Guo RX; Ge X; Qiao YH
    Zhonghua Fu Chan Ke Za Zhi; 2012 Apr; 47(4):292-6. PubMed ID: 22781117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 17 beta-estradiol activates PI3K/Akt signaling pathway by estrogen receptor (ER)-dependent and ER-independent mechanisms in endometrial cancer cells.
    Guo RX; Wei LH; Tu Z; Sun PM; Wang JL; Zhao D; Li XP; Tang JM
    J Steroid Biochem Mol Biol; 2006 Apr; 99(1):9-18. PubMed ID: 16567092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estradiol and tamoxifen induce cell migration through GPR30 and activation of focal adhesion kinase (FAK) in endometrial cancers with low or without nuclear estrogen receptor α (ERα).
    Tsai CL; Wu HM; Lin CY; Lin YJ; Chao A; Wang TH; Hsueh S; Lai CH; Wang HS
    PLoS One; 2013; 8(9):e72999. PubMed ID: 24039841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 17β-Estradiol on the Expression of G-Protein Coupled Estrogen Receptor (GPER/GPR30) Mitophagy, and the PI3K/Akt Signaling Pathway in ATDC5 Chondrocytes In Vitro.
    Fan DX; Yang XH; Li YN; Guo L
    Med Sci Monit; 2018 Apr; 24():1936-1947. PubMed ID: 29608013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen affects the negative feedback loop of PTENP1-miR200c to inhibit PTEN expression in the development of endometrioid endometrial carcinoma.
    Chen R; Zhang M; Liu W; Chen H; Cai T; Xiong H; Sheng X; Liu S; Peng J; Wang F; Chen H; Lin W; Xu X; Zheng W; Jiang Q
    Cell Death Dis; 2018 Dec; 10(1):4. PubMed ID: 30584245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogenic G protein-coupled receptor 30 signaling is involved in regulation of endometrial carcinoma by promoting proliferation, invasion potential, and interleukin-6 secretion via the MEK/ERK mitogen-activated protein kinase pathway.
    He YY; Cai B; Yang YX; Liu XL; Wan XP
    Cancer Sci; 2009 Jun; 100(6):1051-61. PubMed ID: 19432902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-424 suppresses estradiol-induced cell proliferation via targeting GPER in endometrial cancer cells.
    Zhang H; Wang X; Chen Z; Wang W
    Cell Mol Biol (Noisy-le-grand); 2015 Nov; 61(7):96-101. PubMed ID: 26638889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-29b Inhibits Angiogenesis by Targeting VEGFA through the MAPK/ERK and PI3K/Akt Signaling Pathways in Endometrial Carcinoma.
    Chen HX; Xu XX; Tan BZ; Zhang Z; Zhou XD
    Cell Physiol Biochem; 2017; 41(3):933-946. PubMed ID: 28222438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. G protein-coupled receptor 30 mediates cell proliferation of goat mammary epithelial cells via MEK/ERK&PI3K/AKT signaling pathway.
    Zhao Y; Liu H; Fan M; Miao Y; Zhao X; Wei Q; Ma B
    Cell Cycle; 2022 Oct; 21(19):2027-2037. PubMed ID: 35659445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulating the GPR30 estrogen receptor with a novel tamoxifen analogue activates SF-1 and promotes endometrial cell proliferation.
    Lin BC; Suzawa M; Blind RD; Tobias SC; Bulun SE; Scanlan TS; Ingraham HA
    Cancer Res; 2009 Jul; 69(13):5415-23. PubMed ID: 19549922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor effect of XCT790, an ERRα inverse agonist, on ERα-negative endometrial cancer cells.
    Kokabu T; Mori T; Matsushima H; Yoriki K; Kataoka H; Tarumi Y; Kitawaki J
    Cell Oncol (Dordr); 2019 Apr; 42(2):223-235. PubMed ID: 30706380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of the molecular targeted drug, erlotinib, against endometrial cancer expressing high levels of epidermal growth factor receptor.
    Nishimura T; Nakamura K; Yamashita S; Ikeda S; Kigure K; Minegishi T
    BMC Cancer; 2015 Dec; 15():957. PubMed ID: 26673416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.